Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer.
about
Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma.Epigenetic silencing of the XAF1 gene is mediated by the loss of CTCF binding.TR3 modulates platinum resistance in ovarian cancer.Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.Sublytic C5b-9 triggers glomerular mesangial cell apoptosis via XAF1 gene activation mediated by p300-dependent IRF-1 acetylation.IAPs on the move: role of inhibitors of apoptosis proteins in cell migration.microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP.MicroRNA-509-3p increases the sensitivity of epithelial ovarian cancer cells to cisplatin-induced apoptosis.Stimulation of the hypoxia pathway modulates chemotherapy resistance in Hodgkin's lymphoma cells.Clinicopathological correlation of endocan expression and survival in epithelial ovarian cancer.Development and Validation of a Histological Method to Measure Microvessel Density in Whole-Slide Images of Cancer Tissue.Caspase 8 expression may determine the survival of women with ovarian cancer.Inhibitors of apoptosis: clinical implications in cancer.Sublytic C5b-9 Induces Glomerular Mesangial Cell Apoptosis through the Cascade Pathway of MEKK2-p38 MAPK-IRF-1-TRADD-Caspase 8 in Rat Thy-1 Nephritis.
P2860
Q34221867-7AB08E02-7EA9-4290-8F77-28FF94D3CC6DQ36129174-10454E58-6456-4042-AD1D-3669040EFFBBQ37620325-120EC713-0604-4596-A4AC-8E3057F26315Q37716498-9EC7D730-6CFC-46F8-AE5F-35436608C94AQ37726137-6C0F3C10-710A-4B63-BDE2-FB3DDF032C3FQ38134633-3D4FD32C-1961-4049-9148-AF9FF4F24630Q38729639-FDF3C11C-6FBA-431D-96D9-B8BF5AA5CDE9Q38801567-736A0C5E-CBFD-4FB5-AC58-840B8CC41CDEQ38807893-9E22B7D7-DAE9-4629-A674-2D28CD08394FQ38984247-7FF7B6DD-B239-43D0-BB47-078E02E1C708Q39432968-3DE4A65D-2626-4C5A-A3A6-ACACAF72A44AQ42923164-C51EF4AC-57AF-40E3-ACBC-660E6E34FC7EQ47607136-41A18085-0E0F-4AF1-8138-ED3C0E9DC9A7Q51225202-A4A724BB-B110-498D-9BC0-1208325AA825
P2860
Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Association of expression of X ...... -resistance in ovarian cancer.
@en
Association of expression of X ...... -resistance in ovarian cancer.
@nl
type
label
Association of expression of X ...... -resistance in ovarian cancer.
@en
Association of expression of X ...... -resistance in ovarian cancer.
@nl
prefLabel
Association of expression of X ...... -resistance in ovarian cancer.
@en
Association of expression of X ...... -resistance in ovarian cancer.
@nl
P2093
P1433
P1476
Association of expression of X ...... -resistance in ovarian cancer.
@en
P2093
HongLuan Mao
Liang Shen
PeiShu Liu
QingZhi Hao
ShanYing Huang
YongMei Yang
YunXia Wang
P356
10.1016/J.REGPEP.2012.06.005
P577
2012-07-01T00:00:00Z